scholarly article | Q13442814 |
P356 | DOI | 10.2174/157016112798829742 |
P698 | PubMed publication ID | 22112353 |
P50 | author | Vasilios G. Athyros | Q37837494 |
P2093 | author name string | Konstantinos Tziomalos | |
Dimitri P Mikhailidis | |||
Asterios Karagiannis | |||
P433 | issue | 1 | |
P304 | page(s) | 33-41 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | Current Vascular Pharmacology | Q15751349 |
P1476 | title | Lipid lowering agents and the endothelium: an update after 4 years | |
P478 | volume | 10 |
Q89687386 | Endocan and a novel score for dyslipidemia, oxidative stress and inflammation (DOI score) are independently correlated with glycated hemoglobin (HbA1c) in patients with prediabetes and type 2 diabetes |
Q61796690 | Endocan as a marker of microvascular inflammation in kidney transplant recipients |
Q37260183 | Plasma endocan level and prognosis of immunoglobulin A nephropathy |
Q41779175 | Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia |